Apyx Medical/APYX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Apyx Medical

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.

Ticker

APYX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Charles Goodwin

Employees

252

Headquarters

Clearwater, United States

Apyx Medical Metrics

BasicAdvanced
$57M
Market cap
-
P/E ratio
-$0.66
EPS
1.25
Beta
-
Dividend rate
$57M
1.24607
$7.97
$1.21
146K
5.866
4.939
165.181
165.279
-9.21%
-35.94%
-81.01%
-46.73%
1.133
2.822
2.822
14.25%
-9.78%
23.62%

What the Analysts think about Apyx Medical

Analyst Ratings

Majority rating from 5 analysts.
Buy

Apyx Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-73.52% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$10M
-30.14%
Net income
-$7.5M
-21.88%
Profit margin
-73.52%
11.82%

Apyx Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 2.61%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.13
-$0.28
-$0.22
-
Expected
-$0.07
-$0.11
-$0.18
-$0.21
-$0.20
Surprise
-56.77%
14.84%
57.66%
2.61%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Apyx Medical stock?

Apyx Medical (APYX) has a market cap of $57M as of June 14, 2024.

What is the P/E ratio for Apyx Medical stock?

The price to earnings (P/E) ratio for Apyx Medical (APYX) stock is 0 as of June 14, 2024.

Does Apyx Medical stock pay dividends?

No, Apyx Medical (APYX) stock does not pay dividends to its shareholders as of June 14, 2024.

When is the next Apyx Medical dividend payment date?

Apyx Medical (APYX) stock does not pay dividends to its shareholders.

What is the beta indicator for Apyx Medical?

Apyx Medical (APYX) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Apyx Medical stock price target?

The target price for Apyx Medical (APYX) stock is $3.63, which is NaN% below the current price of $. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Apyx Medical stock

Buy or sell Apyx Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing